BSEBoard Meeting4 Aug 2026 · 4 Aug 2026, 05:52 pm
Fermenta Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve unaudited financial results ....
Fermenta Biotech Ltd · 506414
✦ AI SummaryResults
Fermenta Biotech Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 11/08/2026 to consider and approve unaudited financial results for the quarter ended June 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Fermenta Biotech Ltd - 506414 - Board Meeting Intimation for Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30, 2026.
Attachments (1)
📄pdf
Download →
fa020e75-6fce-469a-82dc-c92f244c2ce1.pdf
View document text
August 4, 2026
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot No. C/1,
Dalal Street, Fort, G Block, Bandra - Kurla Complex,
Mumbai – 400 001 Bandra (East), Mumbai 400 051
Scrip Code: 506414 Trading Symbol: FERMENTA
Dear Sir,
Sub: Notice of the Board Meeting
Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, we hereby inform you that the meeting of the Board of Directors of the
Company is scheduled to be held on Tuesday, August 11, 2026, inter alia, to consider and
approve the unaudited financial results of the Company (standalone and consolidated) for the
quarter ended June 30, 2026.
In accordance with the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, the
Company's Code of Conduct to Regulate, Monitor and Report Trading by Insiders, in terms of
BSE Circular LIST/COMP/01/2019-20 dated April 2, 2019 and the Company’s intimation (to BSE
Limited) regarding closure of trading window vide letter dated June 29, 2026, the “Trading
Window" period (for trading in Company’s securities) has been closed with effect from July 1,
2026 and shall continue to remain closed till 48 hours after the declaration of unaudited financial
results pursuant to the Board meeting to be held on August 11, 2026. During the closure of
Trading Window, all Directors, Promoters, Insiders, Designated Persons and their immediate
relatives and also Auditors and other Connected Persons shall not, directly or indirectly trade or
deal or enter into any transaction involving sale or purchase of the Company’s Equity Shares,
either in their own name or in the name of their immediate relatives.
Terms not defined in this notice shall have the same meaning as defined in the Securities and
Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015,
the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and
the Company's Code of Conduct to Regulate, Monitor and Report Trading by Insiders.
This is for your information and record.
Thanking you,
Yours faithfully,
For Fermenta Biotech Limited
Varadvinayak Khambete
Company Secretary & Head - Legal
Membership No. A33861